NeoStem Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma

By: via Benzinga
NeoStem, Inc. (Nasdaq: NBS), a biopharmaceutical company developing novel cell-based individualized medicine therapies, announced today ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.